A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 1, 2003, Pages 13-17

  Gibbons, Simon ^a   Oluwatuyi, Moyosoluwa ^a   Kaatz, Glenn W ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GG918; Multidrug efflux; Staphylococcus aureus

Indexed keywords

BACTERIAL PROTEIN; CARRIER PROTEIN; CIPROFLOXACIN; ELACRIDAR; ERYTHROMYCIN; GLYCOPROTEIN P; LEVOFLOXACIN; MOXIFLOXACIN; MULTIDRUG RESISTANCE PROTEIN; NORFLOXACIN; PROTEIN INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EXPOSURE; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; IN VITRO STUDY; MAMMAL; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; TUMOR CELL;

ACRIDINES; ISOQUINOLINES; MICROBIAL SENSITIVITY TESTS; P-GLYCOPROTEINS; STAPHYLOCOCCUS AUREUS; TETRAHYDROISOQUINOLINES;

EID: 0037259896     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg044     Document Type: Article

References (20)

1. Ling, V. (1997). Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemotherapy and Pharmacology 40, Suppl., S3-8.
2. Marshall, N. J. & Piddock, L. J. V. (1997). Antibacterial efflux systems. Microbiologia 13, 285-300.
3. Littlejohn, T. G., Paulsen, I. T., Gillespie, M. T., Tennent, J. M., Midgley, M., Jones, I. G. et al. (1992). Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiology Letters 74, 259-65.
4. Ubukata, K., Itoh-Yamashita, N. & Konno, M. (1989). Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 33, 1535-9.
5. Ross, J. I., Eady, E. A., Cove, J. H., Cunliffe, W. J., Baumberg, S. & Wootton, J. C. (1990). Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Molecular Microbiology 4, 1207-14.
6. Guay, G. G., Khan, S. A. & Rothstein, D. M. (1993). The tet(K) gene of plasmid pT181 of Staphylococcus aureus encodes an efflux protein that contains 14 transmembrane helices. Plasmid 30, 163-6.
7. Hyafil, F., Vergely, C., Du Vignaud, P. & Grand-Perret, T. (1993). In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Research 53, 4595-602.
8. Malingré, M. M., Beijnen, J. H., Rosing, H., Koopman, F. J., Jewell, R. C., Paul, E. M. et al. (2001). Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients. British Journal of Cancer 84, 42-7.
9. Malingré, M. M., Terwogt, J. M., Beijnen, J. H., Rosing, H., Koopman, F J., van Tellingen, O. et al. (2000). Phase I and pharmacokinetic study of oral paclitaxel. Journal of Clinical Oncology 18, 2468-75.
10. Markham, P. N., Westhaus, E., Klyachko, K., Johnson, M. E. & Neyfakh, A. A. (1999). Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 43, 2404-8.
11. Guz, N. R., Stermitz, F. R., Johnson, J. B., Beeson, T. D., Willen, S., Hsiang, J. et al. (2001). Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships. Journal of Medicinal Chemistry 44, 261-8.
12. Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A. & Lewis, K. (2000). Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proceedings of the National Academy of Sciences, USA 97, 1433-7.
13. Kaatz, G. W., Seo, S. M. & Ruble, C. A. (1993). Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 37, 1086-94.
14. Kaatz, G. W., Moudgal, V. V. & Seo, S. M. (2002). Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 50, 833-8.
15. National Committee for Clinical Laboratory Standards. (1999). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Villanova, PA, USA.
16. Kaatz, G. W., Seo, S. M., O'Brien, L., Wahiduzzaman, M. & Foster, T. J. (2000). Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 44, 1404-6.
17. Takenouchi, T., Tabata, F., Iwata, Y., Hanzawa, H., Sugawara, M. & Ohya, S. (1996). Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 40, 1835-42.
18. Kuroda, M., Ohta, T., Uchiyama, I., Baba, T., Yuzawa, H., Kobayashi, I. et al. (2001). Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 357, 1225-40.
19. Renau, T. E., Leger, R., Flamme, E. M., Sangalang, J., She, M. W., Yen, R. et al. (1999). Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone levofloxacin. Journal of Medicinal Chemistry 42, 4928-31.
20. Markham, P. N. (1999). Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine. Antimicrobial Agents and Chemotherapy 43, 988-9.